A detailed history of Aquilo Capital Management, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Aquilo Capital Management, LLC holds 1,165,466 shares of STRO stock, worth $4.92 Million. This represents 5.14% of its overall portfolio holdings.

Number of Shares
1,165,466
Previous 420,649 177.06%
Holding current value
$4.92 Million
Previous $1.8 Million 264.97%
% of portfolio
5.14%
Previous 1.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.27 - $5.65 $2.44 Million - $4.21 Million
744,817 Added 177.06%
1,165,466 $6.58 Million
Q4 2023

Feb 14, 2024

BUY
$2.07 - $4.54 $870,743 - $1.91 Million
420,649 New
420,649 $1.8 Million

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $220M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Aquilo Capital Management, LLC Portfolio

Follow Aquilo Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.